← All educational resources

Long COVID Was the Third Weight: Why the Virus Broke Some People and Not Others

2026-10-31

Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.

Print the one-page card (PDF): the levers, up front, on a single sheet.

Wallet-size medical information card to fill in with your clinician: ME/CFS and long COVID (10-up sheet) · POTS (10-up sheet).

I have said this in three other posts and it deserves its own: I do not think COVID created a new disease. I think it found people who were already carrying two weights on a shelf built for one, and it added the third. The shelf broke. What came out looked like POTS, or fibromyalgia, or mast cell activation, or crushing fatigue, or all of them at once, and it got a new name, long COVID.

This matters because it changes the plan. If long COVID is a brand new disease, you wait for a brand new approach. If it is the third weight on a shelf, you take the other two weights off, and that you can start today.

If the model is right: the levers, up front

  1. Stop pushing. Pacing with data (morning HRV) is the first approach, not the last.
  2. Salt, water, and compression if you are dizzy or racing when you stand.
  3. Four weeks low-histamine if you flush, react, or feel wired after eating.
  4. Supplements, in order: magnesium, omega-3 with a meal, creatine and phosphatidylcholine, hydroxocobalamin and adenosylcobalamin B12, the mitochondrial stack, apigenin at night, vitamin C, NAC and glycine.
  5. Sleep flat, keep cool, protect your sleep like it is medicine, because it is.
  6. Ask for the tests that find the three weights: methylmalonic acid, homocysteine, ferritin, vitamin D, plasma heparin and urinary prostaglandin metabolites, a morning cortisol, and an EBV panel.
  7. Ask your prescriber about low-dose naltrexone and a trial of H1 plus H2 antihistamines as bridges.

The three weights

I wrote about the shelf in my POTS post here. Quick version: the smallest nerves in your body, the ones that run your autopilot (heart rate, blood vessels, gut, sweat) and carry pain, are fragile and need constant repair. Three things stack up to overwhelm that repair:

Weight one: the nerves are not fed. Low-normal B12, folate, B1, iron, copper, omega-3, vitamin D, magnesium. Most people were carrying this one before 2020 without knowing it.

Weight two: jumpy mast cells. Immune cells spraying histamine and other chemicals on the nerves and blood vessels. Flushing, hives, food reactions, reflux, a racing heart after meals. A lot of people had a mild version of this before they got sick, especially the bendy ones.

Weight three: the repair crew is overwhelmed. Methylation, the chemical process that rebuilds nerves, clears histamine and stress hormones, and makes the energy carriers your mitochondria need, gets used up faster than it is refilled when the body is fighting something for months.

COVID is uniquely good at adding weight three, and at making weights one and two heavier at the same time.

What the virus actually does

It parks itself. Viral protein and RNA have been found in the gut lining, lymph nodes, and other tissues many months after the infection, and in some people the immune system keeps responding to it. A long immune response is a long drain on the repair crew.

It wakes up the mast cells. The spike protein activates mast cells directly, and a large fraction of long COVID patients meet criteria for mast cell activation. If your long COVID came with new food reactions, flushing, hives, or a racing heart after meals, this is why.

It damages the small nerves. Skin biopsies in long COVID patients with pain, dizziness, and tingling frequently show the same small fiber loss seen in POTS and fibromyalgia. The autopilot nerves are the ones that got hit.

It makes antibodies that attack the autopilot. Some long COVID patients make antibodies against the receptors the nervous system uses to control heart rate and blood vessels. The body is, in effect, interfering with its own autopilot.

It injures the blood vessel lining and leaves tiny clots. Long COVID blood shows clots that resist being broken down, and the vessel lining stays inflamed. That means less oxygen delivery to tissues that are already struggling, and more sparks (oxidative stress).

It knocks the power plants offline. Muscle biopsies in long COVID with exercise intolerance show damaged mitochondria and a shift to burning sugar inefficiently. This is the post-exertional crash: do too much, pay for days.

It drains serotonin. The lingering viral response reduces absorption of the amino acid serotonin is made from and lowers blood serotonin, which affects the vagus nerve, memory, and mood.

It reactivates old viruses. Epstein-Barr virus, which most adults carry quietly, wakes up in a large share of long COVID patients and adds its own immune drain.

It pushes cortisol down. Morning cortisol runs low in long COVID cohorts, which means less of the hormone that keeps mast cells quiet and inflammation in check.

Every one of those is a methylation drain, a mast cell trigger, or a nutrient drain. That is the third weight.

Why some people and not others

Because the first two weights were already on the shelf. The people I see with the worst long COVID were, before the infection: bendy, or already a little dizzy on standing, or already reacting to wine and leftovers, or already low on iron and B12, or carrying methylation gene variants that made the repair crew slow to begin with, or burned out from years of stress and poor sleep. None of those was disabling on its own. The virus did not need to do much. It only had to be the third weight.

That is also the hopeful part. The virus is not something you can remove. The other two weights are.

What the model predicts would help, and why

This is the POTS plan with long COVID-specific edits. I will not repeat every detail; the POTS post has the full nerve-feeding diet and the exercise progression.

1. First, the crashes

Pacing comes first. Post-exertional crashes are not a sign you need to push harder. They are a sign the power plants ran out and you spent energy you did not have, and every crash sets the nerve repair back a week. Track morning heart rate variability with a wearable or the Visible app. A low morning is a rest day. Do not start any exercise program until you can go two weeks without a crash. When you do start, it is recumbent (bike, rowing, swimming), five to ten minutes, and the POTS post has the schedule. Graded exercise that ignores crashes has harmed a lot of long COVID patients, and the model argues against it.

Salt, water, compression, and sleep flat if you are dizzy or racing on standing. Details in the POTS post, including why I do not raise the head of the bed.

2. Diet

Feed the nerves: protein at every meal, eggs, red meat, small oily fish (not tuna), liver or desiccated liver capsules weekly, seeds, greens. The full per-meal targets are in the POTS post.

Four weeks low-histamine if you have any mast cell symptoms: no leftovers older than a day, aged cheese, cured meat, wine and beer, vinegar, fermented foods, tomatoes, spinach, eggplant. Cook fresh, freeze same day.

Protein, fat, and fiber at every meal, nothing sweet to drink, and no alcohol. Alcohol is a mast cell trigger, a methylation drain, and a sleep wrecker, which is three strikes.

Smaller meals more often. A big meal pulls blood to the gut and sets off a crash in a lot of long COVID patients.

3. Supplements, in order

Add one a week. The long COVID body reacts badly to fast changes.

  1. Magnesium 300 to 400 mg at night (glycinate), or Seeking Health Magnesium Malate by day.
  2. Omega-3 2 grams EPA plus DHA with a meal that has fat (Carlson). The raw material for nerve membranes and for the molecules that switch inflammation off.
  3. Creatine 5 grams and phosphatidylcholine 1,200 to 2,400 mg with food. This pair frees up your methylation budget for nerve repair and histamine clearance without taking methyl donors, which long COVID patients tolerate badly. If you have ever gotten wired on methylfolate, read my methyl trapping post here.
  4. B12 as hydroxocobalamin plus adenosylcobalamin 1,000 mcg under the tongue in the morning. Hydroxocobalamin is the form that gets knocked out by inflammation and needs replacing. Then a plain B complex with folinic acid, B2, and P5P from a quarter dose.
  5. The mitochondrial stack: CoQ10 as ubiquinol 200 mg with a meal, then acetyl-L-carnitine 1,000 mg in the morning, then alpha lipoic acid 300 to 600 mg. Skip the alpha lipoic acid if pregnant, planning to be, or breastfeeding.
  6. Apigenin 50 mg at bedtime for the mast cells, and luteolin 100 mg by day if daytime flushing and reactions are prominent.
  7. Vitamin C liposomal 1,000 mg (Dr. Mercola's), and vitamin D3 with K2 to a blood level of 50 to 70.
  8. NAC 600 mg twice a day and glycine 3 grams at night to rebuild glutathione, which long COVID burns through.
  9. Tryptophan 500 mg at bedtime if mood, memory, and sleep are flat. Long COVID drains serotonin and this is the raw material.
  10. Iron only if ferritin is under 50; vitamin E as tocotrienols (Procapsin) a few weeks in for the vessel lining.
  11. Nattokinase 2,000 FU twice a day on an empty stomach is used by some clinicians for the resistant clots; the data is early, and it thins blood, so only with your prescriber and never alongside anticoagulants.

4. Lifestyle

  • Sleep is the lever. 8 to 9 hours, same schedule, dark, cool, flat. Nerves repair and the brain rinses inflammation only during deep sleep.
  • Heat is the enemy while the autopilot is down. Cool showers, cooling vest, no sauna until much better.
  • Slow breathing four in, six out, five minutes two or three times a day. It is the cheapest way to turn down the stress side of the autopilot and calm mast cells.
  • Morning light within an hour of waking to rebuild the cortisol rhythm.
  • Lower the chemical load: fragrance-free, filtered water, HEPA in the bedroom. Every mast cell trigger you remove is weight you do not have to carry.
  • Protect against reinfection during the repair window. Each reinfection is another third weight.
  • Bridges worth asking a prescriber about: a trial of an H1 plus H2 antihistamine (cetirizine or fexofenadine plus famotidine) for four weeks, which helps a large share of long COVID patients and tells you how much of your picture is mast cells; and low-dose naltrexone, which calms the immune cells in the brain and spinal cord and has early trials in long COVID fatigue and brain fog. Beta blockers, ivabradine, midodrine, and fludrocortisone are reasonable POTS bridges while the nerves regrow.

5. Markers that would find the weights

Methylmalonic acid and homocysteine (the real B12 and methylation tests), ferritin, vitamin D, red cell magnesium, omega-3 index, plasma heparin and urinary prostaglandin metabolites (not tryptase, which is usually normal), a morning cortisol, an EBV reactivation panel, D-dimer, free T3 with TSH, and a stool test for the gut. If dizziness on standing is prominent, an active stand test and, if it is contested, a skin biopsy for small fiber density.

The sequence the model predicts

Pacing and the volume measures change the day-to-day within two weeks. Mast cell calming shows up in four to eight weeks. The nerve repair and mitochondrial recovery take three to nine months, and the exercise program, started only once the crashes have stopped, is what locks it in. Recovery is lumpy: you will have good weeks and bad weeks, and a bad week after a good one is normal, not failure. Track monthly, not daily.

Educational content written from a research perspective, not medical advice. I am a PhD scientist, not a physician, and I do not diagnose, treat, cure, or prevent disease. What you have read is a model of what might be going on and what the published research suggests would address each piece if the model is right. Please take anything you want to try to your own healthcare provider, especially if you take prescription medication or have kidney, liver, or heart disease.

Thesis

Post-acute sequelae of SARS-CoV-2 (long COVID) are heterogeneous, but the dominant phenotype in my research consulting work (orthostatic intolerance, post-exertional malaise, mast cell symptoms, small fiber sensory symptoms, cognitive impairment, unrefreshing sleep) is the same phenotype I was already modeling as acquired autonomic small fiber neuropathy with mast cell activation and one-carbon exhaustion. I do not think SARS-CoV-2 created a new disease. I think it is an unusually efficient way of adding the third of three insults to a nervous system already carrying two, and of making the first two heavier at the same time. The practical consequence is that the approach the model implies is the POTS, MCAS, and mitochondrial sequence with virus-specific additions, not a wait for a novel therapeutic.

The three insults, from the POTS post here: substrate failure for axonal maintenance; chronic mast cell mediator exposure at the neurovascular junction; and exhaustion of one-carbon (methylation) capacity. Connective tissue laxity, gut dysbiosis, and HPA downregulation are amplifiers.

1. What SARS-CoV-2 adds, mechanism by mechanism

Viral persistence and sustained immune activation. Spike protein, nucleocapsid, and viral RNA are detectable in gut mucosa, lymphoid tissue, and plasma for months in a subset of patients, with ongoing T cell activation and interferon signaling. Chronic immune activation raises SAMe demand (lymphocyte proliferation, polyamine synthesis), raises glutathione consumption, and sustains cytokine exposure of small fibers. This is the most direct route to the third weight.

Mast cell activation. Spike protein activates mast cells directly, in part through MRGPRX2-independent and ACE2-associated mechanisms, and a large fraction of long COVID patients meet MCAS consensus criteria on symptom scoring. Mast cell mediator exposure at perivascular nerve terminals is the second weight, and as in the other MCAS cases I have worked through, the useful markers are plasma heparin and urinary PGD2 metabolites rather than tryptase.

Small fiber neuropathy. Skin biopsy series in long COVID with neuropathic and autonomic symptoms report reduced intraepidermal nerve fiber density in roughly half to two-thirds of cases, with corneal confocal microscopy showing the same. Mechanisms include direct inflammatory injury, mediator-driven degeneration, and immune-mediated ganglionopathy.

Autoantibodies against GPCRs. Functional autoantibodies to alpha-1, beta-1, beta-2 adrenergic, M2 muscarinic, and angiotensin II type 1 receptors are reported in long COVID and post-COVID POTS cohorts at rates comparable to pre-pandemic POTS, and immunoadsorption and IVIG have small positive series. I read these as a consequence of the same immune activation and measure them when the picture is strongly hyperadrenergic or abrupt in onset.

Endotheliitis and fibrinolysis-resistant microclots. Spike protein induces endothelial activation and amyloid-like fibrin(ogen) aggregates that resist fibrinolysis and trap inflammatory proteins; platelet hyperactivation accompanies them. The consequence is impaired microvascular oxygen delivery to tissues already under oxidative load, and additional ROS from endothelial NADPH oxidase and uncoupled NOS (BH4 is depleted by the same inflammation). This is a long COVID-specific amplifier of the ROS load discussed in the connective tissue post here.

Mitochondrial dysfunction and post-exertional malaise. Skeletal muscle biopsies in long COVID with exercise intolerance show reduced mitochondrial oxidative capacity, lower succinate dehydrogenase-positive fibers, amyloid-containing deposits, capillary rarefaction, and a shift toward glycolytic metabolism, with exercise producing further muscle damage and infiltration in PEM-prone patients. Exercise prescribed on a fixed schedule without regard to PEM worsens this population; pacing to symptom and HRV thresholds is the only defensible first step.

Serotonin depletion. Persistent viral RNA sensing through TLR3 and type I interferon reduces intestinal tryptophan absorption (through ACE2-coupled B0AT1 downregulation), increases MAO-mediated serotonin turnover, and reduces platelet serotonin storage, producing low circulating serotonin, reduced vagal afferent signaling, and hippocampal memory impairment in both patients and models. This is a tractable node (tryptophan, 5-HTP where appropriate, vagal training).

Herpesvirus reactivation. EBV reactivation (EBV early antigen IgG, EBV DNA) is found in a substantial fraction of long COVID patients and associates with fatigue and neurocognitive symptoms; HHV-6 and VZV reactivation are reported. Each adds immune load and SAMe demand.

HPA downregulation. Morning cortisol is roughly half of control values in several long COVID cohorts, without ACTH elevation, consistent with central downregulation. Low cortisol removes the principal endogenous brake on mast cell degranulation and inflammatory signaling.

Gut dysbiosis. Reduced diversity, depletion of butyrate producers (Faecalibacterium, Eubacterium), enrichment of opportunists, and persistent gut viral antigen; the barrier defect raises LPS and histamine load and impairs absorption of iron, B12, magnesium, and thiamine.

Oxidation of the methylation machinery. Peroxynitrite from uncoupled NOS and activated macrophages oxidizes cob(I)alamin on methionine synthase; BH4 is oxidized to BH2. Functional B12 and folate deficiency, elevated homocysteine, reduced SAMe:SAH, and limited monoamine synthesis follow, all with normal serum B12 and folate.

2. Why some people and not others

Because the first two weights were already there. The pre-morbid features I find in the worst long COVID cases I have worked through are hypermobility, pre-existing mild orthostatic intolerance, pre-existing food and alcohol reactivity, low-normal ferritin and B12, methylation-relevant genotypes (MTHFR, MTR, MTRR, COMT, HNMT), prior EBV or other post-viral fatigue, and prolonged stress with poor sleep. Each of these is a weight on the shelf; SARS-CoV-2 supplied the third. This also predicts, correctly in my experience, that reinfection is disproportionately harmful in this group and that recovery tracks the removal of the pre-existing weights more than any antiviral measure.

Markers that would test the model

  • One-carbon and substrate: methylmalonic acid, homocysteine, serum and RBC folate, holotranscobalamin; ferritin and transferrin saturation; copper, ceruloplasmin, zinc; RBC magnesium; 25-OH vitamin D; plasma thiamine or erythrocyte transketolase; omega-3 index
  • Mast cell: plasma heparin, urinary 11-beta-PGF2-alpha and N-methylhistamine (24-hour, refrigerated), chromogranin A; tryptase interpreted cautiously
  • Autonomic and small fiber: active stand test; skin biopsy for IENFD and sweat gland fiber density when contested; adrenergic, muscarinic, and AT1 receptor autoantibodies when hyperadrenergic or abrupt-onset
  • Endothelial and coagulation: D-dimer, fibrinogen, von Willebrand factor antigen, hs-CRP; microclot assays where available (research-grade)
  • Mitochondrial: urinary organic acids with mitochondrial intermediates, lactate:pyruvate, acylcarnitine profile, plasma free carnitine; 31P-MRS or CPET with a two-day sequence in specialist settings when PEM is severe
  • Endocrine: four-point cortisol curve with awakening response, DHEA-S; TSH, free T4, free T3, reverse T3
  • Infectious: EBV VCA IgG, EA-D IgG, EBNA IgG, EBV DNA PCR; HHV-6 where symptoms suggest
  • Gut: comprehensive stool analysis with calprotectin, zonulin, SCFAs; breath test for SIBO
  • Serotonin axis: plasma tryptophan and kynurenine:tryptophan ratio where available
  • Beighton score and connective tissue history
  • Genotype where it changes management: MTHFR, MTR, MTRR, COMT V158M, HNMT, AOC1, CBS, SOD2, GSTM1/T1, TNXB, COL5A1

What the model predicts: addressing each node

The sequence: stop post-exertional crashes first, restore volume and orthostatic tolerance, remove mast cell and dietary mediator load, replete substrate with methyl-sparing support before any methyl donor, restore mitochondrial cofactors and redox capacity, address the long COVID-specific nodes (serotonin, endothelium, EBV, cortisol), and introduce graded recumbent exercise only when PEM is controlled. The full dietary targets and the exercise progression are in the POTS post; this section covers the additions and modifications.

Diet

  • As for POTS: protein 1.4 to 1.6 g/kg at four to five smaller meals; 1.5 times RDA neurotrophic targets from food; small oily fish and liver or desiccated liver; sodium 6 to 10 g NaCl with 2 to 3 L fluid when orthostatic.
  • Histamine restriction for four weeks when mast cell signs are present, then systematic reintroduction.
  • Alcohol removed for the repair phase: DAO inhibition, mast cell release, slow-wave sleep suppression, glutathione consumption.
  • Glycemic load control and no caloric beverages; postprandial hypotension and reactive hypoglycemia are common PEM triggers.
  • Tryptophan-adequate protein (poultry, eggs, dairy, seeds) with attention to absorption; the gut lesion is where serotonin precursor supply fails.

Supplements, in the order the model suggests

One agent per week; this population reacts badly to rapid change.

  1. Magnesium glycinate or malate 300 to 400 mg elemental.
  2. Omega-3 2 to 3 g EPA plus DHA, re-esterified triglyceride form, with a fat-containing meal: resolvin and protectin precursors for the resolution of neuroinflammation and endotheliitis.
  3. Methyl-sparing substrates: creatine 5 g and phosphatidylcholine 1,200 to 2,400 mg with food, retiring the GAMT and PEMT debts and freeing SAMe for HNMT, COMT, and myelin methyltransferases. Methyl donors are introduced, if at all, only after this and only after demonstrated tolerance; the hyperadrenergic long COVID person is the archetypal methyl-trapping patient (see the methyl trapping post here).
  4. Hydroxocobalamin plus adenosylcobalamin 1,000 to 2,000 mcg sublingual in the morning; IM hydroxocobalamin 1 mg weekly for eight weeks when MMA is elevated or SFN is documented. Hydroxocobalamin reactivates oxidized methionine synthase and scavenges nitric oxide. Non-methylated B complex (folinic acid, riboflavin-5-phosphate, P5P, benfotiamine) from quarter dose.
  5. Mitochondrial stack: ubiquinol 200 to 300 mg with a meal; acetyl-L-carnitine 1,000 to 1,500 mg in the morning; R-alpha-lipoic acid 300 to 600 mg. ALA withheld in pregnancy, planned pregnancy, and breastfeeding. D-ribose 5 g three times daily as a two-week trial when PEM is severe.
  6. Mast cell stabilization: apigenin 50 mg at bedtime; luteolin 100 mg by day; DAO 10,000 to 20,000 HDU before uncontrolled meals; mixed tocotrienols 100 to 200 mg after several weeks for membrane protection of the regenerating axon and the endothelium.
  7. Redox: liposomal vitamin C 1 to 2 g (mast cell stabilization, BH4 regeneration, DBH cofactor); NAC 600 mg twice daily or liposomal glutathione 250 to 500 mg; glycine 3 g at night; selenium 100 to 200 mcg.
  8. Vitamin D3 to 50 to 70 ng/mL with K2.
  9. Serotonin axis: L-tryptophan 500 mg at bedtime, or 5-HTP 50 to 100 mg, when mood, memory, and sleep are flat and no serotonergic drug is on board.
  10. Iron bisglycinate every other day with vitamin C when ferritin is under 50; copper only when serum copper or ceruloplasmin is low after dietary liver.
  11. Endothelial and fibrinolytic support, with their prescriber: nattokinase 2,000 FU twice daily on an empty stomach, or lumbrokinase, is used by a number of long COVID clinicians on the microclot rationale; the evidence is early and observational, the agents are antithrombotic, and they are never combined with anticoagulants or antiplatelets without supervision. Dietary nitrate (beets, leafy greens) and folate support NOS coupling, with the caution that vasodilation can worsen orthostatic pooling early.
  12. EBV reactivation, where documented: lysine 1 to 3 g, zinc balanced with copper, vitamin C, and sleep; antivirals (valacyclovir) through their prescriber in symptomatic reactivation with supporting serology.
  13. Low-dose naltrexone 1.5 to 4.5 mg at bedtime, by prescription: TLR4 antagonism on microglia, reduced central glial activation; early trials in long COVID report improved fatigue, cognition, and pain, with a benign side-effect profile. it is a question worth taking to a prescriber.
  14. H1 plus H2 antihistamine trial (cetirizine or fexofenadine plus famotidine) for four weeks: a large observational series reported symptomatic improvement in the majority of long COVID patients, and the response is diagnostic of the mast cell contribution. It is a bridge while the root-cause work proceeds, not a maintenance plan. Cromolyn or ketotifen where food-triggered symptoms dominate.

Lifestyle

  • Pacing before exercise. Post-exertional malaise is a hard stop. Morning HRV (RMSSD) via wearable or the Visible app; a reading more than one standard deviation below the rolling baseline is a rest day. No structured exercise until two weeks free of PEM; then the recumbent progression from the POTS post, gated by symptoms, never by schedule. Fixed-schedule graded exercise therapy is not recommended in PEM-positive long COVID.
  • Volume and compression: sodium and fluid loading, waist-high compression or abdominal binder, counter-maneuvers; the person sleeps flat (no head-of-bed elevation, for the cerebral perfusion reasons in the POTS post).
  • Sleep: 8 to 9 hours, fixed schedule, dark and cool; screening for sleep-disordered breathing; morning outdoor light within an hour of waking to rebuild the cortisol awakening response.
  • Thermal management: heat avoidance while the autonomic picture is active.
  • Vagal training: slow breathing at 5 to 6 breaths per minute, 5 minutes two to three times daily; cold-water face immersion and humming for acute surges. Vagal afferent signaling is reduced by serotonin depletion, so this is a direct counter-measure.
  • Environmental load: fragrance-free products, filtered water, HEPA filtration in the bedroom, mold assessment with any water-damage history.
  • Reinfection avoidance during the repair window; each reinfection re-adds the third weight.
  • Where prescribed medications fit: beta blockers, ivabradine, midodrine, fludrocortisone, and pyridostigmine are reasonable autonomic bridges; the goal is to reduce the need for them over 6 to 12 months as small fibers regenerate.

Markers to follow, and the sequence the model predicts

Symptom burden, orthostatic measures, and PEM frequency monthly; MMA, homocysteine, ferritin, cortisol, and mast cell markers at 12 weeks; omega-3 index, copper, EBV serology, and D-dimer at six months; skin biopsy repeat at 12 months if baseline was done. Pacing and volume measures change daily function within two weeks; the antihistamine trial and mast cell stabilization act within four to eight weeks; mitochondrial and serotonin support change energy and cognition over four to twelve weeks; small fiber regeneration and sustained orthostatic tolerance track the exercise program from month three to month nine. The trajectory is non-linear, and a bad week after a good one is expected, not evidence of failure.

Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. The sequences described are what this model predicts would address each node if the model is correct, with the supporting literature cited in the text; they are offered for discussion with a qualified clinician, who should manage any agent with contraindications or interactions.